Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms

The introduction of immunosuppressant belatacept, an inhibitor of the CD28-80/86 pathway, has improved 1-year outcomes in kidney transplant recipients with preexistent diabetes mellitus and has also reduced the risk of posttransplant diabetes mellitus. So far, no studies have compared a tacrolimus-b...

Descripción completa

Detalles Bibliográficos
Autores principales: de Graav, Gretchen N., van der Zwan, Marieke, Baan, Carla C., Janssen, Joop A.M.J.L., Hesselink, Dennis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912016/
https://www.ncbi.nlm.nih.gov/pubmed/29707621
http://dx.doi.org/10.1097/TXD.0000000000000767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912016/
https://www.ncbi.nlm.nih.gov/pubmed/29707621
http://dx.doi.org/10.1097/TXD.0000000000000767

Ejemplares similares